Donor‐derived cell‐free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta‐analysis
VPWM Wijtvliet, P Plaeke, S Abrams… - Transplant …, 2020 - Wiley Online Library
A systematic review and meta‐analysis were performed to investigate the value of donor‐derived
cell‐free DNA (dd‐cfDNA) as a noninvasive biomarker in diagnosing kidney allograft …
cell‐free DNA (dd‐cfDNA) as a noninvasive biomarker in diagnosing kidney allograft …
mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?
With the roll-out of coronavirus disease 2019 (COVID-19) vaccines, it has become clear that
vaccinating the majority of the population worldwide will be the most important element to …
vaccinating the majority of the population worldwide will be the most important element to …
SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies
VPWM Wijtvliet, S Verheyden, B Depreter… - Transplant …, 2022 - Elsevier
Background SARS-CoV-2 vaccination is strongly recommended in kidney transplant recipients
(KTR) and dialysis patients. Whether these vaccinations may trigger alloantibodies, is still …
(KTR) and dialysis patients. Whether these vaccinations may trigger alloantibodies, is still …
New insights in the management of infectious diseases in kidney transplant patients and dialysis patients
VPWM Wijtvliet - 2022 - repository.uantwerpen.be
This thesis is the result of several research projects on infectious diseases in kidney transplant
patients and dialysis patients at the Laboratory of Experimental Medicine and Pediatrics, …
patients and dialysis patients at the Laboratory of Experimental Medicine and Pediatrics, …
[PDF][PDF] mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?
J Ledeganck - scholar.archive.org
In this study of the humoral immune response after the SARS-CoV-2 mRNA vaccination, low
seroconversion rates were noted in both kidney transplant recipients and dialysis patients …
seroconversion rates were noted in both kidney transplant recipients and dialysis patients …
